URBN
55
-11
ALL
48
-2
HSIC
42
-3
EXR
55
-4
ETR
65
-3
DFS
64
-3
PNR
71
-3
ED
43
-2
APD
54
2
TGT
50
-2
OXY
52
-3
NDAQ
59
-4
ILMN
42
-3
STX
50
-2
AEE
60
-3
INTC
39
-10
RRC
58
-2
MOS
42
3
LB
30
-22
TXT
58
-4
URBN
55
-11
ALL
48
-2
HSIC
42
-3
EXR
55
-4
ETR
65
-3
DFS
64
-3
PNR
71
-3
ED
43
-2
APD
54
2
TGT
50
-2
OXY
52
-3
NDAQ
59
-4
ILMN
42
-3
STX
50
-2
AEE
60
-3
INTC
39
-10
RRC
58
-2
MOS
42
3
LB
30
-22
TXT
58
-4
Financhill
Back

Vera Therapeutics Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Buy
73

VERA
Vera Therapeutics

Last Price:
48.99
Seasonality Move:
65.96%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Vera Therapeutics Price Quote

$48.99
-0.01 (-0.83%)
(Updated: November 15, 2024 at 4:52 AM ET)

Vera Therapeutics Key Stats

Buy
73
Vera Therapeutics (VERA) is a Buy
Day range:
$48.06 - $50.19
52-week range:
$12.28 - $51.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
10.73%
Volume:
642.4K
Avg. volume:
918.2K
1-year change:
259.77%
Market cap:
$3.1B
Revenue:
$0
EPS:
$-2.61

How Much Does Vera Therapeutics Make?

Data Unavailable

Is Vera Therapeutics Growing As A Company?

Data Unavailable

Vera Therapeutics Stock Price Performance

What Is Vera Therapeutics 52-Week High & Low?

Vera Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vera Therapeutics?

  • How Much Debt Does Vera Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vera Therapeutics Have?
    Cash and short term investments quarterly total is $353.3M
  • What Is Vera Therapeutics’s Book Value Per Share?
    Book value per share is 5.25

Is Vera Therapeutics Cash Flow Positive?

  • What Is VERA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$120.6M
  • What Is Vera Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $305.5M
  • What Is Vera Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$185.1M

Vera Therapeutics Return On Invested Capital

Data Unavailable

Vera Therapeutics Earnings Date & Stock Price

Vera Therapeutics Competitors

  • Who Are Vera Therapeutics's Competitors?
    Below is a list of companies who compete with Vera Therapeutics or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • PROCEPT BioRobotics Corp (PRCT)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Vera Therapeutics Dividend Yield

Vera Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -38.73%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 63.91
Upside from Last Price: 30.43%

Major Shareholders

  • How many VERA shares are owned by institutional investors?
    76.6M VERA shares are owned by institutional investors
  • How many VERA shares are owned by insiders?
    615.9K VERA shares are owned by insiders